Cargando…
Widening Consumer Access to Medicines through Switching Medicines to Non-Prescription: A Six Country Comparison
BACKGROUND: Switching or reclassifying medicines with established safety profiles from prescription to non-prescription aims to increase timely consumer access to medicines, reduce under-treatment and enhance self-management. However, risks include suboptimal therapy and adverse effects. With a long...
Autores principales: | Gauld, Natalie J., Kelly, Fiona S., Kurosawa, Nahoko, Bryant, Linda J. M., Emmerton, Lynne M., Buetow, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175460/ https://www.ncbi.nlm.nih.gov/pubmed/25251434 http://dx.doi.org/10.1371/journal.pone.0107726 |
Ejemplares similares
-
Widening Consumer Access to Medicines: A Comparison of Prescription to Non-Prescription Medicine Switch in Australia and New Zealand
por: Gauld, Natalie J., et al.
Publicado: (2015) -
Consumers' experiences and values in conventional and alternative medicine paradigms: a problem detection study (PDS)
por: Emmerton, Lynne, et al.
Publicado: (2012) -
Behavioural aspects surrounding medicine purchases from pharmacies in Australia
por: Emmerton, Lynne
Publicado: (2008) -
Sharing science: a new era of widening access to research in reproductive medicine
por: Bhattacharya, Siladitya
Publicado: (2017) -
Analysing the landscape for prescription to non-prescription reclassification (switch) in Germany: an interview study of committee members and stakeholders
por: Gauld, Natalie J.
Publicado: (2019)